A New, Rapid, Fully Automated Method for Determination of Fluconazole in Serum by Column-Switching Liquid Chromatography

A sensitive and rapid HPLC assay for the determination of fluconazole in serum is described. HPLC-integrated sample preparation allows direct injection of serum samples without any pretreatment. The in-line extraction technique is carried out by automatically switching from the extraction column (Lichrospher® ADS C8) to the analytic column (Nucleosil C18). After 6 minutes the matrix passes the extraction column, and the retained analyte is quantitatively transferred to the analytic column, where separation by isocratic HPLC is performed. The extraction eluent is sodium dihydrogen phosphate buffer, pH 5.0 (50 mM), and the analytic eluent is acetonitrile/sodium dihydrogen phosphate buffer, pH 5.0 (50 mM) (26.8/73.2, vol/vol). Fluconazole is detected according to its absorption maximum at 210 nm. The lower limit of quantification (LLOQ) is 0.65 μg/mL, the limit of detection (LOD) is 0.2 μg/mL, and the quantification range is 0.65–23.3 μg/mL. The assay was precise with a between-run coefficient of variation of ≤ 5.59%. The within-run accuracy was 99.8% and 103.4%, and the between-run accuracy was 99.2% and 99.7%, respectively, for the concentrations 23.3 μg/mL and 1.3 μg/mL. The recovery was 78%. The described procedure allows sample cleanup and determination within 20 minutes, thereby facilitating drug monitoring in clinical routine. The method was applied successfully.

[1]  M. Ehrlich,et al.  New and rapid fully automated method for determination of tazobactam and piperacillin in fatty tissue and serum by column-switching liquid chromatography. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[2]  L. Decosterd,et al.  Single-step extraction of fluconazole from plasma by ultra-filtration for the measurement of its free concentration by high performance liquid chromatography. , 2002, Journal of pharmaceutical and biomedical analysis.

[3]  M. Ghannoum,et al.  Antifungal Susceptibility Testing: Practical Aspects and Current Challenges , 2001, Clinical Microbiology Reviews.

[4]  M. Ehrlich,et al.  A new and rapid method for monitoring the new oxazolidinone antibiotic linezolid in serum and urine by high performance liquid chromatography-integrated sample preparation. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[5]  D. Sanglard,et al.  Sensitive Bioassay for Determination of Fluconazole Concentrations in Plasma Using a Candida albicans Mutant Hypersusceptible to Azoles , 2001, Antimicrobial Agents and Chemotherapy.

[6]  Y. Kanda,et al.  Serum levels of fluconazole in patients after cytotoxic chemotherapy for hematological malignancy , 2001, American journal of hematology.

[7]  M. Ehrlich,et al.  Rapid antibiotic drug monitoring: meropenem and ceftazidime determination in serum and bronchial secretions by high-performance liquid chromatography-integrated sample preparation. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[8]  M. Takada,et al.  Fluconazole-Induced Convulsions at Serum Trough Concentrations of Approximately 80 &mgr;g/mL , 2000, Therapeutic drug monitoring.

[9]  M. Jemal,et al.  Direct injection versus liquid-liquid extraction for plasma sample analysis by high performance liquid chromatography with tandem mass spectrometry. , 1999, Rapid communications in mass spectrometry : RCM.

[10]  G. Corso,et al.  Fluconazole bioequivalence study: quantification by tandem mass spectrometry. , 1999, Therapeutic drug monitoring.

[11]  A. Penk,et al.  Dosage adjustment of fluconazole during continuous renal replacement therapy (CAVH, CVVH, CAVHD, CVVHD) , 1999, Mycoses.

[12]  J. Faucher,et al.  Unusual outcome of disseminated candidiasis treated with fluconazole: a matter of pharmacokinetics? , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  A. Penk,et al.  [Pharmacokinetics and dosage of fluconazole in continuous hemofiltration (CAVH, CVVH) and hemodialysis (CAVHD, CVVHD)]. , 1998, Mycoses.

[14]  J. Graybill,et al.  Therapeutic drug monitoring of systemic antifungal therapy. , 1997, The Journal of antimicrobial chemotherapy.

[15]  W. Hurford,et al.  Fluconazole Serum Concentrations and Pharmacokinetics in an Obese Patient , 1997, Pharmacotherapy.

[16]  D. Spence,et al.  Variability of plasma fluconazole levels in patients with hematologic malignancy. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  F. Bressolle,et al.  High-performance liquid chromatographic determination of fluconazole in plasma. , 1996, Journal of chromatography. B, Biomedical applications.

[18]  F. von Heeren,et al.  Determination of fluconazole in human plasma by micellar electrokinetic capillary chromatography with detection at 190 nm. , 1996, Journal of chromatography. A.

[19]  H. Dermoumi,et al.  Serum level determination of fluconazole by high-performance liquid chromatography and bioassay. , 1996, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[20]  H. Rosing,et al.  High-performance liquid chromatographic determination of the antifungal drug fluconazole in plasma and saliva of human immunodeficiency virus-infected patients. , 1995, Journal of chromatography. B, Biomedical applications.

[21]  D. Lubda,et al.  Alkyl-Diol Silica (ADS): restricted access precolumn packings for direct injection and coupled-column chromatography of biofluids , 1995 .

[22]  F. Flores-Murrieta,et al.  A Simple and Rapid Method for Determination of Fluconazole in Human Plasma Samples by High-Performance Liquid Chromatography , 1994 .

[23]  J. Böhler,et al.  Drug Dosage in Patients during Continuous Renal Replacement Therapy , 1993, Clinical pharmacokinetics.

[24]  D. Debruyne,et al.  Clinical Pharmacokinetics of Fluconazole , 1993, Clinical pharmacokinetics.

[25]  M. Gill,et al.  Determination of fluconazole in human serum by solid-phase extraction and reversed-phase high-performance liquid chromatography. , 1992, Therapeutic drug monitoring.

[26]  M. Rinaldi,et al.  Assay of fluconazole by high-performance liquid chromatography with a mixed-phase column , 1992, Antimicrobial Agents and Chemotherapy.

[27]  D. Stevens,et al.  Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography , 1991, Antimicrobial Agents and Chemotherapy.

[28]  M. Gardner,et al.  Induction of Fluconazole Metabolism by Rifampin: In Vivo Study in Humans , 1991, Journal of clinical pharmacology.

[29]  I. Yoshiya,et al.  Rapid determination of serum levels of a new antifungal agent, fluconazole, by high-performance liquid chromatography. , 1990, Journal of chromatography.

[30]  O. Zee,et al.  A sensitive and simplified HPLC analysis for the determination of fluconazol in human plasma , 1988 .